Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone in complex regional pain syndrome
NCT02502162Recruiting
- Sponsor
- Stanford University
- Start
- Jun 2015
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in complex regional pain syndrome (CRPS) comparing LDN with Placebo (2 arms). Primary endpoint: Changes in pain severity at 4 weeks. Started Jun 2015; status: recruiting.
02
Drugs
naltrexone
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT02502162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502162.